Cargando…
Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing
BACKGROUND: Thrombotic microangiopathies (TMA) are serious medical conditions requiring a prompt diagnosis to adapt treatment. The determination of ADAMTS-13 activity enables discriminating thrombotic thrombocytopenic purpura (TTP) from other forms of TMA. The purpose of this study was to provide an...
Autores principales: | Merlen, Clémence, Pépin, Emmanuelle, Barry, Ousmane, Cormier, Anik, Dubois, Caroline, Lapeyraque, Anne-Laure, Troyanov, Stéphan, Rivard, Georges-Etienne, Bonnefoy, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351225/ https://www.ncbi.nlm.nih.gov/pubmed/35927768 http://dx.doi.org/10.1186/s13023-022-02409-3 |
Ejemplares similares
-
Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis
por: Genest, Dominique S., et al.
Publicado: (2022) -
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
por: Sarig, Galit
Publicado: (2014) -
Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review
por: McFarlane, Philip A., et al.
Publicado: (2021) -
The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies
por: Phillips, E. H., et al.
Publicado: (2016) -
Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)